ASHP Midyear 2025 Clinical Meeting & Exhibition December 8-10, 2025 | Las Vegas, NV Featuring some of the most innovative technologies and products, the exhibit
DexCom, Inc., the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age
Dexcom Continuous Glucose Monitoring (CGM) is proven to lower A1C and increase time in range.1-3,5,6 Dexcom ranks #1 in patient satisfaction,† adherence, and retention.7-9,‡ Company
Dexcom G7 is clinically proven to improve glycemic outcomes1-5 >1% A1C reduction after 12 weeks1,2,5 >1 hour increase in time in range for T1D and
McKesson ideaShareJuly 10 -13, 2025 | Nashville, TN McKesson ideaShare is the nation’s leading event for community pharmacy, designed to empower both current and future
MERCHANDISING: DME, DEVICES Pharmacies, particularly community/retail, sell a wide variety of items beyond prescription medications. These products can be categorized into several groups and are
Cardinal Health RBC July 9-12, 2025 | Denver, CO The Cardinal Health Retail Business Conference (RBC) is an annual conference recognizing independent pharmacies and their
Dexcom Continuous Glucose Monitoring (CGM) features demonstrate proven outcomes in A1C reduction, time in range (TIR), and improved device adherence.1,2,5,6 Dexcom ranks #1 in patient
The Dexcom G7 is a next-generation continuous glucose monitoring (CGM) system that is redefining diabetes management through real-time data, ease of use, and clinical accuracy.
Dexcom G7 15 Day* is now cleared in the US for people age 18 years and above with diabetes. Now the longest lasting*,†,1 and most
